CSIR Central

Inhalable Microparticles Containing Isoniazid and Rifabutin Target Macrophages and “Stimulate the Phagocyte” to Achieve High Efficacy

IR@CDRI: CSIR-Central Drug Research Institute, Lucknow

View Archive Info
 
 
Field Value
 
Creator Yadav, A B
Sharma, Rolee
Muttil, Pavan
Singh, A K
Verma, R K
Mohan, Mradul
Patel, S K
Misra, Amit
 
Date 2010-12-11T07:25:53Z
2010-12-11T07:25:53Z
2009
 
Identifier Indian J Exp Biol. 2009, 47(6):469-74
http://hdl.handle.net/123456789/640
 
Description Macrophage responses to infection with Mycobacterium tuberculosis (MTB) and treatment with soluble isoniazid (INH) plus rifabutin (RFB) versus microparticles containing equivalent amounts of drugs were compared. It was investigated whether macrophages driven to alternative activation upon infection with MTB could be rescued to display the classical activation phenotype. It was established that microparticles sustain high levels of drugs in the cytosol of macrophages for longer periods as compared to soluble drugs. Microparticles co-localized with intracellular bacteria, and induced a variety of innate bactericidal responses, including induction of free radicals, alteration of mitochondrial membrane potential and apoptosis. The data strongly suggest that additional benefit may be derived from the nature of the drug delivery system, which fulfils Koch’s dictum for curing tuberculosis: “stimulate the phagocyte”.
 
Format 246524 bytes
application/pdf
 
Language en
 
Subject Mycobacterium tuberculosis
intracellular bacteria
anti-TB
phagocytosis
bactericidal macrophage
rifabutin (RFB)
 
Title Inhalable Microparticles Containing Isoniazid and Rifabutin Target Macrophages and “Stimulate the Phagocyte” to Achieve High Efficacy
 
Type Article